- Info
- Insider Trading
- Financials
- Holders: LYEL, LYEL
Current Ratio of Lyell Immunopharma, Inc. from 31 Mar 2022 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Lyell Immunopharma, Inc. quarterly Current Ratio in x history and change rate from 31 Mar 2022 to 31 Dec 2025.
- Lyell Immunopharma, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 7.4x, a 40% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Lyell Immunopharma, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 7.4x | -4.98x | -40% | 31 Dec 2025 |
| Q3 2025 | 7.93x | -7.6x | -49% | 30 Sep 2025 |
| Q2 2025 | 8.59x | -7.79x | -48% | 30 Jun 2025 |
| Q1 2025 | 10.28x | -6.46x | -39% | 31 Mar 2025 |
| Q4 2024 | 12.38x | -5.22x | -30% | 31 Dec 2024 |
| Q3 2024 | 15.53x | -2.45x | -14% | 30 Sep 2024 |
| Q2 2024 | 16.38x | -0.19x | -1.1% | 30 Jun 2024 |
| Q1 2024 | 16.74x | +1.37x | +8.9% | 31 Mar 2024 |
| Q4 2023 | 17.6x | +3.11x | +21% | 31 Dec 2023 |
| Q3 2023 | 17.98x | +4.36x | +32% | 30 Sep 2023 |
| Q2 2023 | 16.57x | +3.65x | +28% | 30 Jun 2023 |
| Q1 2023 | 15.37x | +2.47x | +19% | 31 Mar 2023 |
| Q4 2022 | 14.5x | 31 Dec 2022 | ||
| Q3 2022 | 13.62x | 30 Sep 2022 | ||
| Q2 2022 | 12.92x | 30 Jun 2022 | ||
| Q1 2022 | 12.9x | 31 Mar 2022 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.